Stocktoria
Huntsman CORP HUN
NYSE · XNYS · stock · Chemicals & Allied Products · website · IPO 2005-02-11
Huntsman CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.7B | $6.0B | $6.1B | $8.0B | $7.7B |
| Gross profit | $751.0M | $866.0M | $906.0M | $1.5B | $1.6B |
| R&D expense | $120.0M | $121.0M | $115.0M | $125.0M | $135.0M |
| SG&A expense | $670.0M | $671.0M | $689.0M | $711.0M | $739.0M |
| Operating income | -$131.0M | -$25.0M | $84.0M | $672.0M | $731.0M |
| Income tax | $26.0M | $61.0M | $64.0M | $186.0M | $191.0M |
| Net income | -$284.0M | -$189.0M | $101.0M | $460.0M | $1.0B |
| EPS (diluted) | $-1.65 | $-1.10 | $0.57 | $2.27 | $4.72 |
| Operating cash flow | $298.0M | $285.0M | $251.0M | $914.0M | $952.0M |
| Free cash flow | $125.0M | $101.0M | $21.0M | $642.0M | $626.0M |
| Cash & equivalents | $429.0M | $340.0M | $540.0M | $654.0M | $1.0B |
| Inventory | $818.0M | $917.0M | $867.0M | $995.0M | $1.0B |
| Total assets | $7.0B | $7.1B | $7.2B | $8.2B | $9.4B |
| Total liabilities | $4.1B | $4.0B | $3.8B | $4.4B | $4.8B |
| Shareholders' equity | $3.0B | $3.2B | $3.5B | $3.8B | $4.6B |
Source: SEC EDGAR filings · CIK 0001307954 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.